Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a condition called SLC6A1-NDD, which involves a specific gene mutation, and who experience epilepsy, developmental delays, autism spectrum disorder, or intellectual disability as part of that condition.
- People who are 17 years old or younger at the time of signing up for the trial.
- People who are under 18 years old and have a parent or legal guardian who is able to provide consent on their behalf (and where appropriate, the child themselves may also be asked to agree to participate).
- People whose caregivers are willing and able to follow the study requirements, including keeping a diary and attending scheduled visits.
Who may not be able to join:
- People whose caregivers are unable to attend the required follow-up visits.
- People who have another diagnosed condition — including one caused by a different gene — that is known to cause epilepsy or neurodevelopmental disorders.
- People who are currently taking another experimental treatment (other than a specific medication called 4-phenylbutyrate), or who have taken an experimental treatment within the past 30 days or within a certain timeframe based on how long that treatment stays in the body, whichever is longer (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: UCB Cares, 001 844 599 2273 (UCB)
Phone: +18445992273
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Seizure frequency by type (countable seizures per 28 days) by visit as compared to Baseline; Seizure free days per 28 days by visit as compared to Baseline
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.